A Leading Location
The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value-added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.
Are you planning on developing your company’s presence in the German capital? A good choice! We will help you implement your decision to locate or expand your company in Berlin-Brandenburg.
BioJapan & Regenerative Medicine Japan 2016 October 12-14, 2016
The German biotech company epinamics (http://www.epinamics.com) was granted a patent for its Liqui-Patch® platform technology from the United States Patent and Trademark Office.
Pfizer is constantly exploring opportunities for partnerships and invites you to submit a research collaboration proposal for the 1st Pfizer Biotech Partnering Days on October 4–5, 2016 in Berlin.
Meet the German Capital Region at BioJapan in Yokohama | October 11-14 | Booth #B-48
The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. All the major players in the pharmaceutical industry are very well-represented. However, we also take great...